Bills · 2023-2024 Regular Session
Relating to: a pediatric cancer research tax credit. (FE)
Disease Franchise — Taxation Hospitals and health care facilities Income tax — Credit
- Introduced, stopped here
- Passes Senate, not reached
- Passes Assembly, not reached
- Governor signs, not reached
- Law, not reached
Unfamiliar terms? Glossary
What this bill does
Plain-language analysis by the nonpartisan Legislative Reference Bureau
This bill creates an income and franchise tax credit for contributions made by
a business entity to a pediatric cancer research institution. The bill requires the
institution to use the contribution exclusively and directly for pediatric cancer
research and defines a “pediatric cancer research institution” as a hospital or an
institution of higher education located in this state that is actively conducting
pediatric cancer research, as certified by the secretary of health services.
Under the bill, the maximum amount of the credit that an entity may claim in
any taxable year is $2,500,000. If the amount of the credit exceeds the entity's tax
liability, the entity does not receive a refund but, instead, may claim the remaining,
unused credit against the entity's tax liability in subsequent years.
What it would cost
Fiscal estimates filed by state agencies, as official PDFs
Sponsors
Full history
- Mar 1, 2023 · Senate
Introduced by Senator Jacque; cosponsored by Representatives Bodden, Tusler, Behnke and Donovan
- Mar 1, 2023 · Senate
Read first time and referred to Committee on Universities and Revenue
- Mar 10, 2023 · Senate
Fiscal estimate received
- Jan 10, 2024 · Senate
Representative Gustafson added as a cosponsor
- Apr 15, 2024 · Senate
Failed to pass pursuant to Senate Joint Resolution 1